The identification of the genetic underpinnings of PRKAR1A-related thyroid malignancies and understanding the molecular mechanisms that underlie are of utmost importance, as it will enable the development and advancement of clinical care and treatment strategies that specifically target the PKA pathway and trigger thyroid cancer in patients affected with CNC. Here, PRKAR1A is linked to thyroid cancer.